DNA gyrase, an enzyme unique to prokaryotes, has been implicated in al
most all processes that involve DNA. Although efficient inhibitors of
this protein have been known for more than 20 years, none of them have
enjoyed prolonged pharmaceutical success. It is only recently that th
e mechanisms of inhibition for some of these classes of drugs have bee
n established unequivocally by X-ray crystallography. It is hoped that
this detailed structural information will assist the design of novel,
effective inhibitors of DNA gyrase.